Literature DB >> 18598135

Malonyl-CoA, a key signaling molecule in mammalian cells.

David Saggerson1.   

Abstract

Malonyl-CoA can be formed within the mitochondria, peroxisomes, and cytosol of mammalian cells. Besides being an intermediate in the pathways of de novo fatty acid biosynthesis and fatty acid elongation, malonyl-CoA has an important signaling function through its allosteric inhibition of carnitine palmitoyltransferase 1, the enzyme that normally exerts flux control over mitochondrial beta-oxidation. Malonyl-CoA is rapidly turned over in mammalian cells, and the activities of acetyl-CoA carboxylase and malonyl-CoA decarboxylase are important determinants of its cytosolic concentration. It is now recognized that malonyl-CoA participates in a diverse range of physiological or pathological responses and systems. These include the ketogenic response of the liver to fasting and diabetes, carbohydrate versus fat fuel selection in muscle tissues, metabolic changes in muscle during contracture, alterations in fatty acid metabolism during cardiac ischemia and postischemic reperfusion, stimulation of B cell insulin secretion by glucose, and the hypothalamic control of appetite.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598135     DOI: 10.1146/annurev.nutr.28.061807.155434

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  102 in total

1.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.

Authors:  Donald B Jump; Moises Torres-Gonzalez; L Karl Olson
Journal:  Biochem Pharmacol       Date:  2010-12-22       Impact factor: 5.858

2.  Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.

Authors:  Daniel R Boutz; Patrick J Collins; Uthra Suresh; Mingzhu Lu; Cristina M Ramírez; Carlos Fernández-Hernando; Yufei Huang; Raquel de Sousa Abreu; Shu-Yun Le; Bruce A Shapiro; Angela M Liu; John M Luk; Shelley Force Aldred; Nathan D Trinklein; Edward M Marcotte; Luiz O F Penalva
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

3.  Integrative metabolome and transcriptome profiling reveals discordant energetic stress between mouse strains with differential sensitivity to acrolein-induced acute lung injury.

Authors:  James P Fabisiak; Mario Medvedovic; Danny C Alexander; Jonathan E McDunn; Vincent J Concel; Kiflai Bein; An Soo Jang; Annerose Berndt; Louis J Vuga; Kelly A Brant; Hannah Pope-Varsalona; Richard A Dopico; Koustav Ganguly; Swapna Upadhyay; Qian Li; Zhen Hu; Naftali Kaminski; George D Leikauf
Journal:  Mol Nutr Food Res       Date:  2011-08-08       Impact factor: 5.914

Review 4.  Fatty acid metabolism by the osteoblast.

Authors:  Priyanka Kushwaha; Michael J Wolfgang; Ryan C Riddle
Journal:  Bone       Date:  2017-08-31       Impact factor: 4.398

5.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

6.  Fatty acid metabolism and thyroid hormones.

Authors:  Naomi L Sayre; James D Lechleiter
Journal:  Curr Trends Endocinol       Date:  2012-01-01

7.  Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance.

Authors:  Wei Huang; Rishipal Bansode; Madhu Mehta; Kamal D Mehta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation.

Authors:  Ulrike Bruning; Francisco Morales-Rodriguez; Joanna Kalucka; Jermaine Goveia; Federico Taverna; Karla C S Queiroz; Charlotte Dubois; Anna Rita Cantelmo; Rongyuan Chen; Stefan Loroch; Evy Timmerman; Vanessa Caixeta; Katarzyna Bloch; Lena-Christin Conradi; Lucas Treps; An Staes; Kris Gevaert; Andrew Tee; Mieke Dewerchin; Clay F Semenkovich; Francis Impens; Birgit Schilling; Eric Verdin; Johannes V Swinnen; Jordan L Meier; Rhushikesh A Kulkarni; Albert Sickmann; Bart Ghesquière; Luc Schoonjans; Xuri Li; Massimiliano Mazzone; Peter Carmeliet
Journal:  Cell Metab       Date:  2018-08-23       Impact factor: 27.287

9.  Agaricus bisporus supplementation reduces high-fat diet-induced body weight gain and fatty liver development.

Authors:  María Iñiguez; Patricia Pérez-Matute; María Jesús Villanueva-Millán; Emma Recio-Fernández; Irene Roncero-Ramos; Margarita Pérez-Clavijo; José-Antonio Oteo
Journal:  J Physiol Biochem       Date:  2018-10-04       Impact factor: 4.158

Review 10.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.